The medical sector is growing amid rising health awareness, an aging population, and technological advancements. Moreover, the healthcare sector is largely immune to economic turmoil. So, investors could consider buying Agilent Technologies, Inc. (A), Qiagen N.V. (QGEN), and Harvard Bioscience, Inc. (HBIO). These stocks are Buy-rated in our proprietary rating system.
Revenue in the healthcare market is expected to grow at 12.9% CAGR until 2027, resulting in a market volume of $27.67 billion.
